Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2001, p. 5142-5155, Vol. 21, No. 15
Ludwig Institute for Cancer
Research,1 Department of
Medicine,2 and Cancer
Center,3 University of California, San Diego
School of Medicine, La Jolla, California 92093-0660
Received 7 February 2001/Returned for modification 11 March
2001/Accepted 20 April 2001
EXO1 interacts with MSH2 and MLH1 and has been proposed to be a
redundant exonuclease that functions in mismatch repair (MMR). To
better understand the role of EXO1 in mismatch repair, a genetic screen
was performed to identify mutations that increase the mutation rates
caused by weak mutator mutations such as exo1
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.5142-5155.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
exo1-Dependent Mutator Mutations: Model
System for Studying Functional Interactions in Mismatch
Repair
and
pms1-A130V mutations. In a screen starting with an
exo1 mutation, exo1-dependent mutator mutations
were obtained in MLH1, PMS1, MSH2, MSH3, POL30 (PCNA),
POL32, and RNR1, whereas starting with the weak
pms1 allele pms1-A130V,
pms1-dependent mutator mutations were identified in MLH1, MSH2, MSH3, MSH6, and EXO1. These
mutations only cause weak MMR defects as single mutants but cause
strong MMR defects when combined with each other. Most of the mutations
obtained caused amino acid substitutions in MLH1 or PMS1, and these
clustered in either the ATP-binding region or the MLH1-PMS1 interaction regions of these proteins. The mutations showed two other types of
interactions: specific pairs of mutations showed unlinked
noncomplementation in diploid strains, and the defect caused by pairs
of mutations could be suppressed by high-copy-number expression of a
third gene, an effect that showed allele and overexpressed gene
specificity. These results support a model in which EXO1 plays a
structural role in MMR and stabilizes multiprotein complexes containing
a number of MMR proteins. A similar role is proposed for PCNA based on
the data presented.
*
Corresponding author. Mailing address: Ludwig Institute
for Cancer Research, UCSD School of Medicine-CMME3080, 9500 Gilman Dr., La Jolla, CA 92093-0660. Phone: (858) 534-7804. Fax: (858) 534-7750. E-mail: rkolodner{at}ucsd.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|